Moderna agrees to pay up to $2.25B to settle COVID vaccine patent dispute - Peer2Peer

Virginia Lawyers Acc

Moderna agrees to pay up to $2.25B to settle COVID vaccine patent dispute

Mar 04, 2026

Moderna will pay up to $2.25 billion to Genevant Sciences and Arbutus Biopharma to resolve patent disputes over lipid nanoparticle technology used in its COVID-19 vaccine.

https://valawyersweekly.com/2026/03/04/moderna-agrees-to-pay-up-to-2-25b-to-settle-covid-vaccine-patent-dispute/

Respond, make new discussions, see other discussions and customize your news...
Log in.

To add this website to your home screen:

1. Tap

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Terms of Service